𝔖 Bobbio Scriptorium

✦ LIBER ✦

PCV64 INDEX, FOLLOW-UP AND TOTAL HOSPITALIZATION COSTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES UNDERGOING PLANNED PERCUTANEOUS CORONARY INTERVENTION TREATED WITH PRASUGREL VS. CLOPIDOGREL IN THE TRITON-TIMI 38 TRIAL

✍ Scribed by EM Mahoney; K Wang; Y Lei; SV Arnold; PL McCollam; J Riesmeyer; F Plat; DJ Cohen

Book ID: 119597214
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 73 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)66362-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV42 HOSPITALIZATION COSTS IN SOUTH KOR

PCV42 HOSPITALIZATION COSTS IN SOUTH KOREA FOR PATIENTS WITHOUT IDENTIFIED RISK FACTORS FOR BLEEDING WHO HAVE ACUTE CORONARY SYNDROMES WITH PLANNED PERCUTANEOUS CORONARY INTERVENTION TREATED WITH PRASUGREL VS. CLOPIDOGREL IN THE TRITON-TIMI 38 TRIAL

✍ E Mahoney; K Wang; BM Yang; BRM Kim; HY Lee; IH Chae; SY Kang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PCV87 COST-EFFECTIVENESS OF PRASUGREL VE

PCV87 COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AND PLANNED PCI: RESULTS FROM THE TRITON-TIMI 38 TRIAL FROM THE GERMAN PERSPECTIVE

✍ EM Mahoney; K Wang; PL McCollam; C Schmitt; DJ Cohen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PCV126 REDUCTION IN REHOSPITALIZATIONS A

PCV126 REDUCTION IN REHOSPITALIZATIONS AND ASSOCIATED COSTS WITHIN 30 DAYS AFTER DISCHARGE FROM HOSPITALIZATION FOR ACUTE CORONARY SYNDROMES AND PLANNED PCI WITH PRASUGREL VS. CLOPIDOGREL: RESULTS FROM THE TRITON-TIMI 38 TRIAL FOR PATIENTS WITH NO HISTORY OF STROKE OR TIA

✍ EM Mahoney; K Wang; JP Bae; B Zhu; MD Marciniak; MB Effron; DJ Cohen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Early and Late Benefits of Prasugrel in

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: A TRITON–TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel–Thrombolysis In Myocardial Infarction) Analysis

✍ Elliott M. Antman; Stephen D. Wiviott; Sabina A. Murphy; Juri Voitk; Yonathan Ha 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 287 KB

Effect of prasugrel versus clopidogrel o

Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)–Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy

✍ Yuri B. Pride; Stephen D. Wiviott; Jacqueline L. Buros; Cafer Zorkun; M. Umer Ta 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 177 KB

The Efficacy and Safety of Prasugrel Wit

The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention: A TRITON–TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis In Myocardial Infarction 38) Analysis

✍ Michelle O'Donoghue; Elliott M. Antman; Eugene Braunwald; Sabina A. Murphy; P. G 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 480 KB